Telix Pharmaceuticals Statistics
NASDAQ: TLXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
11.12+0.34 (+3.15%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Telix Pharmaceuticals by the numbers
Telix Pharmaceuticals has a market capitalization of $3.78 billion based on 339.78M shares outstanding. Its trailing P/E ratio is 111.2. The stock trades 2.4% below its 50-day average and 14.9% above its 200-day average.
Average daily trading volume is 249.35K shares, or about $2.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TLX valuation vs. peer median
| Metric | TLX | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.78B | $3.59B | +5% |
| Avg. volume | 249.35K | 2.35M | -89% |
Peer median across 8 companies: LEGN, TNGX, VKTX, OGN, PBLS, XENE, IDYA, AMLX.
Valuation
- Market cap
- $3.78B
- P/E (TTM)
- 111.20
- EPS (TTM)
- $0.10
- Shares outstanding
- 339.78M
Price and trading
- Previous close
- 10.78
- Open
- 11.01
- Day range
- 11.01 – 11.14
- 52-week range
- 6.28 – 13.11
- 52-week change
- +11.76%
- Beta
- —
- Volume
- 817.43K
- Average volume
- 249.35K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 20, 2025
Additional statistics
- Market Cap
- 3.78B
- Pe
- 111.20
- Forward Pe
- -413.77
- Eps
- 0.10
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 13.11
- Week52 Low
- 6.28
- Avg Volume
- 249.35K
- Shares Outstanding
- 339.78M
- Ma50
- 11.40
- Ma200
- 9.68
- Earnings Date
- Aug 20, 2025
- Pct From52w High
- -15.18%
- Pct From52w Low
- 77.07%